NFKB2 and colorectal carcinoma: Taking together, we establish a PIR‐NIK‐NFκB2‐FAS survival signaling transduction pathway and suggest that PIR is an important survival factor functioning to promote CRC malignancy by inhibiting FAS‐based apoptosis in multiple mechanisms.